Inhaled PGE(1) in neonates with hypoxemic respiratory failure: two pilot feasibility randomized clinical trials

BACKGROUND: Inhaled nitric oxide (INO), a selective pulmonary vasodilator, has revolutionized the treatment of neonatal hypoxemic respiratory failure (NHRF). However, there is lack of sustained improvement in 30 to 46% of infants. Aerosolized prostaglandins I(2) (PGI(2)) and E(1) (PGE(1)) have been...

全面介紹

Na minha lista:
書目詳細資料
發表在:Trials
Main Authors: Sood, Beena G, Keszler, Martin, Garg, Meena, Klein, Jonathan M, Ohls, Robin, Ambalavanan, Namasivayam, Cotten, C Michael, Malian, Monica, Sanchez, Pablo J, Lakshminrusimha, Satyan, Nelin, Leif D, Van Meurs, Krisa P, Bara, Rebecca, Saha, Shampa, Das, Abhik, Wallace, Dennis, Higgins, Rosemary D, Shankaran, Seetha
格式: Artigo
語言:Inglês
出版: BioMed Central 2014
主題:
Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4414424/
https://ncbi.nlm.nih.gov/pubmed/25496504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-486
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍